Successful market access requires insights on strategic key decisions at the national level. Outsourcing to experts who understand the unique market access challenges of the German healthcare system could help smooth the path when entering Europe's biggest pharma market.  

This article outlines how you can tackle the challenges of sustainable market access through successfully navigating marketing, reimbursement and product positioning within the stakeholder framework.

The challenges North American biopharma companies face when entering the European marketplace, the options they have for overcoming these risks, and how to choose the best approach.


Jeremy Broadis, Vice President, International, at Quintiles, UK & Dr. Birgit Friedmann, Senior Director Market Access at Quintiles Commercial Germany GmbH